Among the top ten immune makers correlated with CXCL10, chemokines CCL3 and CCL4 are identified as biomarkers for B cell receptor pathway activation and prognostic serum markers in DLBCL (Takahashi et al., 2015). The gene discussed is CCL4; the disease is diffuse large B-cell lymphoma.